Login
$BAX
$25.54 +$0.00 (0.0%) After hours

$BAX 8-K/A SEC Filings

Filed On Filing
06 Feb 2025 8-K/A: Regulation FD Disclosure

On August 12, 2024, Baxter International Inc. (the “Company”) entered into an Equity Purchase Agreement (as may be amended, amended and restated or otherwise modified from time to time in accordance with its terms, the “Purchase Agreemen...

13 May 2014 8-K/A: Submission of Matters to a Vote of Security Holders

Baxter International Inc. hereby amends its Form 8-K filed on May 8, 2014 to update the table below, included under item 5.07(a), to correct the names of the last two directors to Thomas T. Stallkamp and Albert P.L. Stroucken. The voting...

16 Nov 2012 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

20 Sep 2007 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

27 Jul 2005 8-K/A: Departure/Election of Directors or Officers; Compensation

This Form 8-K/A amends the Form 8-K dated March 23, 2005 filed by Baxter International Inc. (the “Company”), which announced the elections effective March 21, 2005 and March 30, 2005, respectively, of Blake E. Devitt and Peter S. Hellman...

18 Nov 2004 8-K/A: Departure/Election of Directors or Officers; Compensation

This Form 8-K/A amends the Form 8-K filed by Baxter International Inc. (the “Company”) on September 1, 2004, which announced the election of Albert P.L. Stroucken to the Board of Directors of the Company. At that time, it had not been de...

21 Oct 2004 8-K/A: Results of Operations and Financial Condition

Includes plasma-derived hemophilia (FVII, FVIII, FIX and FEIBA), albumin, biosurgery (Tisseel) and other plasma-based products.

23 Jan 2003 8-K/A: Regulation FD Disclosure

Sales Advance 10 Percent in the Fourth Quarter, Full-Year 2002

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support